Below you'll find a list of all posts that have been categorized as “Uncategorized”
When Formula 1 teams hit the track, every decision, from aerodynamics to engine suppliers, reflects disciplined trade-offs. Behind the scenes, leaders face a familiar business dilemma: build or buy the capability, or build, buy, or partner with someone who already has it. This same decision model, known as Build-Buy-Partner (BBP) Analysis, applies across industries. Whether you are shipping a new …
Competitive pricing means setting prices with real-time knowledge of your rivals, your customers, and market context. It is not a race to the bottom. It is a strategic lever that aligns customer value, market conditions, and business objectives. Visit Sedulo Group for broader context on competitive strategy, or explore our Competitive Intelligence Solutions to see how insight turns into action. …
What is the Threat & Opportunity Prioritization Matrix? Consumer industries are flooded with information. From overnight social media trends to shifting regulatory disclosure requirements and evolving distributor behavior, the market is in constant flux. The challenge for today’s leaders isn’t a failure to spot change, but a failure to distinguish which signals require immediate action and which simply need to …
Defining the Matrix in a Retail Context In our main post on the Threat and Opportunity Prioritization Matrix, we outlined how probability, impact, and confidence cut through noise and drive smarter, faster decisions. That framework works across industries, but in Retail the dynamics are especially intense. The pace of consumer shifts, fragile of supply chains, and intense competition mean that …
Defining the Matrix in a Healthcare Context In our main post on the Threat and Opportunity Prioritization Matrix, we explained how combining probability, impact, and confidence helps leaders cut through the noise and prioritize action. While the framework applies broadly, healthcare presents a particularly complex case. The stakes are high, the environment is heavily regulated, and both threats and opportunities …
Introduction In today’s pharmaceutical landscape, the difference between a strong launch and a stalled one can come down to timing, and timing is often dictated by your competitors. Each data release, FDA approval, or early signal from a rival can shift perceptions, alter payer dynamics, and reshape the playing field. Yet many organizations either overreact to competitor milestones — panicking …
Introduction: Reading Between the Headcount Lines When it comes to preparing for a drug launch, few competitive signals speak louder than a change in field force staffing. A spike in sales hiring, a sudden wave of medical science liaison (MSL) activity, or expansion of regional leadership roles can all hint at what your competitors are planning, sometimes months before their …
Introduction: The Objectivity Gap in Pharma Launch Planning Launching a new therapy is one of the highest-stakes events in the pharmaceutical industry, and one of the most resource-intensive. Every decision, from Phase 3 trial design to payer engagement and field deployment, can alter the odds of commercial success. Yet even the most sophisticated pharma organizations face a persistent challenge: objectivity. …
Anticipating the Next Move In pharma, every successful product launch invites a response. As soon as your Phase 3 data is released or your marketing authorization nears, competitors begin planning counter-messaging campaigns, refining claims, adjusting positioning, or engaging key opinion leaders (KOLs) to defend market share. To stay ahead, life sciences teams must go beyond tracking competitor milestones. They need …
